Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

AIMS : To compare the safety and efficacy of edoxaban combined with P2Y(12) inhibition following percutaneous coronary intervention (PCI) in patients with atrial fibrillation (AF) presenting with an acute coronary syndrome (ACS) or chronic coronary syndrome (CCS). METHODS AND RESULTS : In this pre-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vranckx, Pascal, Valgimigli, Marco, Eckardt, Lars, Lewalter, Thorsten, Unikas, Ramunas, Marin, Francisco, Schiele, François, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan, Goette, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767635/
https://www.ncbi.nlm.nih.gov/pubmed/32860041
http://dx.doi.org/10.1093/eurheartj/ehaa617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767635/
https://www.ncbi.nlm.nih.gov/pubmed/32860041
http://dx.doi.org/10.1093/eurheartj/ehaa617

Ejemplares similares